Жилой комплекс площадью более 33 тыс кв м планируют построить в Зеленограде mskagency.ru - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mskagency.ru Daily Mail and Mail on Sunday newspapers.
Uzbekistan to develop test systems for detection of UK variant of COVID-19
AKIPRESS.COM - Researchers in Uzbekistan work on development of test systems for detection of UK variant of COVID-19, the Ministry of Innovative Development reported.
To Read the Full Story
Almost 4,000 volunteers get first shots of China s coronavirus vaccine in Uzbekistan
AKIPRESS.COM - The Advanced Technologies Center under the Ministry of Innovative Development of Uzbekistan and the Virology Research Institute of the Ministry of Health are conducting the third phase of clinical trials of recombinant coronavirus vaccine ZF2001 developed by Chinese company Anhui Zhifei Loncom Biofharmaceutical.
To Read the Full Story
Third stage of clinical trials of China s coronavirus vaccine starts in Uzbekistan
AKIPRESS.COM - The ceremony marking start of the third stage of international clinical trial of a new recombinant coronavirus vaccine in Uzbekistan was held today at the Ministry of Innovative Development.
To Read the Full Story
Third stage of clinical trials of China s coronavirus vaccine starts in Uzbekistan
AKIPRESS.COM - The ceremony marking start of the third stage of international clinical trial of a new recombinant coronavirus vaccine in Uzbekistan was held today at the Ministry of Innovative Development.
The Ministry of Innovative Development and the Ministry of Health started the third stage of clinical trials of coronavirus vaccine developed by Zhifei Longcom Biopharmaceutical Co., Ltd.
Zhifei dispatched 6,000 trial vaccines to Uzbekistan (50% are vaccines and 50% are placebos), 12,000 PCR tests, 8,000 antibodies tests and related supplies (syringes, masks, goggles, pregnancy tests, cryotubes).
5,000 volunteers were selected for trials. Their information will be kept confidential.